Edition:
United Kingdom

Strides Shasun Ltd (STSA.NS)

STSA.NS on National Stock Exchange of India

733.30INR
10:26am GMT
Change (% chg)

Rs7.50 (+1.03%)
Prev Close
Rs725.80
Open
Rs725.80
Day's High
Rs741.50
Day's Low
Rs719.00
Volume
532,717
Avg. Vol
519,102
52-wk High
Rs1,212.45
52-wk Low
Rs641.95

Select another date:

Fri, Feb 9 2018

BRIEF-India's Strides Shasun Dec Qtr Consol Profit Down 56 Pct

* DEC QUARTER CONSOL PROFIT 825.9 MILLION RUPEES VERSUS PROFIT OF 1.87 BILLION RUPEES LAST YEAR

BRIEF-Strides Shasun Says Co Not Participating In Process To Buy Orchid Chemicals & Pharmaceuticals

* CLARIFIES ON NEWS ITEM "BLACKSTONE, STRIDES, NECTAR LEAD RACE FOR ORCHID PHARMA"

BRIEF-Strides Shasun Gets U.S. FDA Nod For Nystatin and Triamcinolone Acetonide Ointment

* SAYS GETS U.S. FDA APPROVAL FOR NYSTATIN AND TRIAMCINOLONE ACETONIDE OINTMENT Source text - http://bit.ly/2nnKyAr Further company coverage:

BRIEF-Strides Shasun Gets U.S. FDA Approval For Piroxicam Capsules

* PRODUCT WILL BE MANUFACTURED AT CO'S ORAL DOSAGE FACILITY AT BANGALORE; WILL BE MARKETED BY STRIDES PHARMA IN U.S. MARKET Source text - http://bit.ly/2EqTVGU Further company coverage:

BRIEF-Strides Shasun Gets U.S. FDA Nod For Tenofovir Disoproxil Fumarate Tablets

* GETS U.S. FDA NOD FOR TENOFOVIR DISOPROXIL FUMARATE TABLETS

BRIEF-Sequent Scientific Gets Shareholders' Nod For Scheme Of Arrangement with Strides Shasun

* GETS SHAREHOLDERS' NOD TO APPROVE SCHEME OF ARRANGEMENT BETWEEN STRIDES SHASUN, CO AND SOLARA ACTIVE PHARMA SCIENCES Source text: (http://bit.ly/2DoTPO4) Further company coverage:

BRIEF-Strides Shasun Gets Shareholders' Nod For Composite Scheme Of Arrangement With Sequent Scientific And Solara Active Pharma Sciences

* GETS SHAREHOLDERS' NOD FOR COMPOSITE SCHEME OF ARRANGEMENT BETWEEN CO, SEQUENT SCIENTIFIC AND SOLARA ACTIVE PHARMA SCIENCES Source text - http://bit.ly/2pNrrDh Further company coverage:

BRIEF-Strides Shasun Acquires Controlling Stake In Trinity Pharma

* SAYS ACQUIRES CONTROLLING STAKE IN TRINITY PHARMA, SOUTH AFRICA

BRIEF-Eris Lifesciences Says ‍Divestment Of Strides Shasun's India Brand Business To Co Completed

* SAYS ‍DIVESTMENT OF STRIDES SHASUN'S INDIA BRAND BUSINESS TO CO COMPLETED Source text - http://bit.ly/2kkCPEo Further company coverage:

BRIEF-Strides Shasun gets U.S. FDA approval for acetazolamide tablets​

* Says product to be marketed by Strides Pharma Inc in the US market‍​ Source text for Eikon: Further company coverage:

Select another date: